Jim Kean

Trammell Crow Co. provides commercial real estate services. The company delivers brokerage, project management, and building management services through its global services group. The company operates in Canada, Europe, Asia-Pacific, and Latin/South America. The company was founded in 1948 and is headquartered in Dallas, TX.

More.com, Inc. sells pharmaceutical products on line. The firm provides medicine products, health and beauty aids, vision care products, nutritional supplements, baby products, and prescription medications. It provides solutions to pharmaceutical, biotechnology, and medical device companies. The company was founded by Don Kendall in November 1997 and is headquartered in New York, NY.

Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland.

Neurotrack Technologies, Inc. engages in the development of behavioral biomarkers to assist with the diagnosis of Alzheimer's disease. Its products remove the need for the eye-tracker, making the test even more accessible and affordable for families and individuals around the globe. The company was founded by Elli Kaplan, Stuart Zola, Elizabeth Buffalo and Cecelia Manzanares in 2012 and is headquartered in Redwood City, CA.

Voyager Capital LLC (Voyager Capital) is a venture capital firm founded in 1997 by Enrique Godreau, William H. McAleer and Tony Audino. The firm is headquartered in Seattle, Washington.

Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999.

New York Philharmonic provides live theatrical presentations. The company was founded in 1842 and is headquartered in New York, NY.

CEO Roundtable on Cancer, Inc. promotes activities to reduce cancer risk, enable early detection, facilitate better access to treatment and hasten the discovery. Its programs include CEO cancer gold standard, life sciences consortium and project data sphere. The company was founded by George H. W. Bush in 2001 and is headquartered in Durham, NC.

Swiss-American Chamber of Commerce is an organization that advocates for Swiss, American, and multinational business interests. The non-profit company is based in Zurich, Switzerland. The Swiss company is active in all three major regions of Switzerland, organizing events and conducting comprehensive studies on business-related topics. The organization's special committees provide valuable input into its operations, and its flagship publication, the Yearbook, contains a member directory and a comprehensive collection of facts and figures on Swiss-U.S. business relations. Martin M. Naville has been the CEO of the company since 2004.

Virgo Associates LLC (Virgo Associates) is a private equity firm founded in 2005 by Hemanth Parasuram and Guhan Swaminathan. The firm is headquartered in Austin, Texas.

Part of Thorne HealthTech, Inc., Thorne Research, Inc. manufactures natural dietary supplements and retails through online. The company is based in Summerville, SC. The company was founded in 1984 by Kelly Czap. Paul F. Jacobson has been the CEO of the company since 2010.

Oak Park Residence Corp. is a property management company that provides apartments for rent in Oak Park, IL. The private company is based in Oak Park, IL. The company has a variety of buildings available for rent and offers an online resident portal for easy communication. The staff is professional and responsive to residents' needs. The company has a mission and history of providing safe and peaceful environments for residents to live in.

Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ.

Helsinn Holding SA is a holding Swiss company that provides cancer services through its subsidiaries. The private company is based in Lugano, Switzerland and has subsidiaries in Switzerland and Ireland. The company was founded in 1976 by Gabriele Edoardo Braglia. Riccardo Braglia has been the CEO of the company since 2002.

Helsinn Birex Pharmaceuticals Ltd. develops and manufactures oral dosage drug products. It is engaged in providing oral solid dosage forms and topical forms of pharmaceutical products and packaging of sterile products. The firm supplies its partners with ready to sell products on an exclusive basis, which are manufactured on site and using a network of external manufacturing partners. The company was founded by Gabriele Braglia on May 18, 1978 and is headquartered in Dublin, Ireland.

Conquer Cancer Foundation of the American Society of Clinical Oncology operates as a non-profit organization that researches in the prevention, treatment, and cure of cancer. Its programs include health information technology platform; patient resources; online medical education; and meetings, symposia, and workshop. The company was founded in 1964 and is headquartered in Alexandria, VA.

Windham Venture Management LLC (Windham Venture Management) is a venture capital firm founded in 2006 by Joe Proto, Roger Fine and Adam Fine. The firm is headquartered in New York.

Cognoa, Inc. offers a mobile application and proprietary algorithm to enable early detection of autism. The firm is a consumer healthcare company that?s changing how parents assess and support their child?s development. The company was founded by Dennis Wall and Brent Vaughan and is headquartered in Palo Alto, CA.

3B FUTURE HEALTH VENTURES SARL (3B Future Health Ventures) is a venture capital subsidiary of Helsinn Healthcare SA founded in 2016. The firm is headquartered in Monaco, Luxembourg.

Everly Well, Inc. provides at-home health tests and completely transformed lab results. It specializes in prevention medicine, wellness, and digital health. The company was founded by Julia Taylor Cheek in 2015 and is headquartered in Austin, TX.

Part of Helsinn Healthcare SA, Helsinn Advanced Synthesis SA develops and manufactures pharmaceutical ingredients. The company is based in Biasca, Switzerland.

Greenbone Ortho SRL develops a wood-derived bone implants technology to generate biomimetic implant suitable to address non-union fractures. It offers GreenBone that reproduce chemical composition and thee-dimensional architecture of natural tissues. The company was founded by Lorenzo Pradella in 2014 and is headquartered in Faenza, Italy.

QuantuMDx Group Ltd. develops devices for diagnostics detection. The firm offers DNA-XT, Under The Tree Diagnostics, Q-POC, and Internet of Life. The company was founded by Jonathan O'Halloran, Elaine Warburton, and Julian Warburton in March 2008 and is headquartered in Newcastle upon Tyne, the United Kingdom.

Storyup, Inc. engages in manufacturing healium products. It offers digital health, fitness, sensors and biometrics, virtual reality & augmented reality and wearable's products. The company was founded in 2014 and is headquartered in Columbia, MO.

Cognito Therapeutics, Inc. is a clinical-stage neurotechnology company based in Cambridge, MA. Cognito Therapeutics is developing disease-modifying therapeutic approaches to treat neurodegenerative disorders using its non-invasive neuromodulation platform. The company's lead therapy is currently in a pivotal study (HOPE) in Alzheimer's disease and has been awarded FDA breakthrough device designation. Cognito Therapeutics is advancing the field of neuromodulation to create novel therapeutics that improve the lives of patients living with neurodegenerative diseases. The company was founded by Li-Huei Tsai and Ed Boyden, and Brent A. Vaughan has been the CEO of the company since 2020.

3B Future Health Fund II S.C. A. SICAV-RAIF invests in companies located in the US, Europe, Israel and Japan. The fund target companies operating in the fields of healthcare. It provides financing for early stage capital requirements with an investment up to USD 12 million. It also makes follow on investment and take a seat on the board of director.